Abstract:Author(s): Wang, Ying | Advisor(s): Tidball, James G | Abstract: Skeletal muscle undergoes progressive mass loss, termed sarcopenia, and increased accumulation of fibrotic tissue during aging, which reduces the life quality of the elderly and causes significant economic burden on healthcare services of society. The importance of the immune system, especially myeloid cells, in modulating muscle growth and regeneration following injury suggests that myeloid cells may also have significant influences on sarcopenia and muscle fibrosis during aging. In this investigation, we studied the regulatory interactions between myeloid cells and skeletal muscle during aging. We found that muscle aging is associated with increased number of anti-inflammatory M2a macrophages that can increase muscle fibrosis. Expression of a muscle-specific transgene of nNOS prevented the age-related increases in M2a macrophage and reduced fibrosis in aging muscle. We then tested whether aging of myeloid cells contributes to the age-related increases in M2a macrophages and the associated increases in fibrosis. Transplantation of young bone marrow cells into old mice resulted in fewer M2a macrophages and less accumulation of collagen compared to age-matched, non-transplant mice. We also found that transplantation of young bone marrow cells into old mice prevented sarcopenia. On the other hand, muscles of young mice receiving old bone marrow cells showed decreased numbers of muscle stem cells, called satellite cells, and increased numbers of fibrogenic-converted satellite cells. In vitro, media conditioned by young, but not old, bone marrow-derived macrophages increased muscle cell proliferation. These data suggest that aging of myeloid cells promotes the shift of satellites cell from a myogenic lineage to a more fibrogenic lineage during aging, and contributes to sarcopenia and muscle fibrosis. However, both the nNOS transgene and the heterochronic bone marrow transplantation can also affect muscle aging through unknown mechanisms other than changes in myeloid cells. To specifically manipulate the myeloid cell population, we designed a mouse line with a myeloid-cell-specific mutation of transcription factor Sfpi1 which specifically reduced the number of M2 macrophages in muscle. Myeloid-cell-specific mutation of Sfpi1 prevented sarcopenia and age-related muscle fibrosis, strongly suggesting that muscle aging is at least partly attributable to myeloid cells. Previous studies in our lab and by other groups suggested that tumor necrotic factor-alpha (TNFα) is a macrophage-derived factor that may contribute significantly to muscle aging. We found that systemic TNFα knockout increased satellite cell fusion into muscle fibers in old muscle and prevented sarcopenia. Furthermore, we observed that transplantation of wild-type bone marrow cells into TNFα knockout mice induced sarcopenia and reduced muscle cell fusion, indicating that TNFα secreted by myeloid cells contributes significantly to the reduction of satellite cell myogenic capacity during aging and causes sarcopenia. Overall, our findings provide insight into mechanisms of muscle aging and the regulatory interactions between myeloid cells and skeletal muscle during aging.

Ang-(1–7) protects skeletal muscle function in aged mice

Ang-(1-7) Protects Skeletal Muscle Function in Aged Mice

Aerobic exercise suppresses CCN2 secretion from senescent muscle stem cells and boosts muscle regeneration in aged mice

Angiotensin-(1-7) improves skeletal muscle regeneration

Reversal of aging-associated increase in myelopoiesis and expression of alarmins by angiotensin-(1-7)

Angiotensin II receptor blockade promotes repair of skeletal muscle through down-regulation of aging-promoting C1q expression

Senolytic treatment rescues blunted muscle hypertrophy in old mice

Exercise restores muscle stem cell mobilization, regenerative capacity and muscle metabolic alterations via adiponectin/AdipoR1 activation in SAMP10 mice.

Restoration of the gut barrier integrity and restructuring of the gut microbiome in aging by angiotensin-(1-7)

Inhibition of MAT2A Impairs Skeletal Muscle Repair Function

AAV-Mediated Nuclear Localized PGC14 Delivery in Muscle Ameliorates Sarcopenia and Aging-Associated Metabolic Dysfunctions

The aging myostatin null phenotype: reduced adiposity, cardiac hypertrophy, enhanced cardiac stress response, and sexual dimorphism

A potential strategy for counteracting age-related sarcopenia: preliminary evidence of combined exercise training and leucine supplementation.

Betaine delays age‐related muscle loss by mitigating Mss51‐induced impairment in mitochondrial respiration via Yin Yang1

AAV‐Mediated nuclear localized PGC1α4 delivery in muscle ameliorates sarcopenia and aging‐associated metabolic dysfunctions

Osteocalcin Inhibits Myocyte Aging Through Promotion of Starvation-Induced Autophagy Via IL-6/STAT3 Signaling

Cardiomyocyte-specific Deletion of Endothelin Receptor A Rescues Aging-Associated Cardiac Hypertrophy and Contractile Dysfunction: Role of Autophagy

Regulatory Interactions Between Myeloid Cells and Skeletal Muscle During Aging

Glucagon-Like Peptide-2 Ameliorates Age-Associated Bone Loss and Gut Barrier Dysfunction in Senescence-Accelerated Mouse Prone 6 Mice

Dietary epicatechin improves survival and delays skeletal muscle degeneration in aged mice

CARDIAC‐SPECIFIC OVEREXPRESSION OF CATALASE PROLONGS LIFESPAN AND ATTENUATES AGEING‐INDUCED CARDIOMYOCYTE CONTRACTILE DYSFUNCTION AND PROTEIN DAMAGE